SYMBIOCELLTECH LLC has a total of 11 patent applications. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are CELLEX CORP, WEIDONG ZHANG and GENEIUS BIOTECHNOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microbiology | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Westenfelder Christof | 10 |
#2 | Hu Zhuma | 5 |
#3 | Gooch Anna | 5 |
#4 | Zhang Ping | 4 |
#5 | Gooch Anna L | 4 |
#6 | Zhan Ping | 1 |
#7 | Anna Gooch | 1 |
#8 | Christof Westenfelder | 1 |
Publication | Filing date | Title |
---|---|---|
AU2018327318A1 | Adaptation of Hollow-Fiber-based cell culture technology for the manufacturing of Neo-Islets or exosomes from stem cells | |
CA2995599A1 | Neo-islets comprising stem and islet cells and treatment of diabetes mellitus therewith | |
WO2015058139A1 | Stem cell / islet cell hybrids, generation thereof, and methods for the treatment and cure of insulin-dependent diabetes mellitus |